The pathogenesis of diabetic nephropathy (Q37209550)

19 August 2017

1 reference

title

The pathogenesis of diabetic nephropathy (English)

1 reference

19 August 2017

0 references

Suma Dronavalli

1

1 reference

19 August 2017

Irena Duka

series ordinal

2

1 reference

19 August 2017

George L Bakris

series ordinal

3

1 reference

19 August 2017

language of work or name

1 reference

8 July 2008

1 reference

Nature Clinical Practice Endocrinology and Metabolism

19 August 2017

published in

1 reference

19 August 2017

volume

4

1 reference

19 August 2017

issue

8

1 reference

19 August 2017

page(s)

444-452

1 reference

Can the nephrologist prevent dialysis-related amyloidosis?

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

Advanced glycosylation end products in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Structural-functional relationships in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

The clinical course of renal function in NIDDM patients with normo- and microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Clinical practice. Nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Pathogenesis of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Molecular mechanisms of diabetic renal hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Cellular and molecular mechanisms of proteinuria in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Type 2 diabetic nephropathy: never too early to treat?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Wnt/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

The Development of Lesions in the Glomerular Basement Membrane and Mesangium After Transplantation of Normal Kidneys to Diabetic Patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Advanced glycation end-products in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Diabetes complications: why is glucose potentially toxic?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Pathogenesis, prevention, and treatment of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Molecular mechanisms of diabetic nephropathy and its therapeutic intervention

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Abnormalities in protein kinase C and MAP kinase cascade in mesangial cells cultured under high glucose conditions

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Plasma prorenin as an early marker of nephropathy in diabetic (IDDM) adolescents

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Renin/prorenin receptors

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Microvascular basement membranes in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

The role of inflammatory cytokines in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Regulation of renal proximal tubular epithelial cell hyaluronan generation: implications for diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Eicosanoids and renal vascular function in diseases.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Physiologic and pathophysiologic roles of lipid mediators in the kidney

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Roles of lipid mediators in kidney injury.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Impact of mitochondrial ROS production on diabetic vascular complications

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Role of oxidative stress in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Podocyte biology and response to injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Diabetic nephropathy: Linking histology, cell biology, and genetics

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND).

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0894

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0894

1 reference

Dimensions Publication ID

19 August 2017

1003657701

0 references

1 reference